Bioequivalence and Bioavailability Forum 05:33 CET

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Enoxaparin sodium injection BA BE studies [Regulatives / Guidelines]

posted by varsha chungde - India, 2018-10-08 11:34  - Posting: # 19415
Views: 966

Hi all,

As per guideline we need not to perform any Bioequivalence studies for Injectables. But Enoxaparin sodium being a biologically derived product, is there any need of performing the BA-BE studies.

Does the guideline differs for a biologically derived product?:confused::confused:confused:

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,154 posts in 4,080 threads, 1,308 registered users;
online 4 (0 registered, 4 guests [including 3 identified bots]).

One can show the following: given any rule, however “fundamental”
or “necessary” for science, there are always circumstances
when it is advisable not only to ignore the rule,
but to adopt its opposite.    Paul Feyerabend

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed